JESSICA ZWOLINSKI: Open Payments
NPI 1619340403 · CALEDONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,892 in 162 payments from 22 companies in 2025. Trend: 2023 $3,795 · 2024 $2,671 · 2025 $2,892
Food & beverage: $2,892
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $399 |
| Incyte Corporation | 11 | $250 |
| Regeneron Healthcare Solutions, Inc. | 7 | $219 |
| Galderma Laboratories, L.P. | 22 | $216 |
| Novartis Pharmaceuticals Corporation | 11 | $208 |
| PFIZER INC. | 18 | $197 |
| UCB, Inc. | 11 | $192 |
| GENZYME CORPORATION | 8 | $179 |
| Arcutis Biotherapeutics, Inc. | 12 | $164 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $158 |
Products named: DUPIXENT, OPZELURA, RINVOQ, Bimzelx, Zoryve, TREMFYA, COSENTYX, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
